PDCD1 and esophageal squamous cell carcinoma: According to previous data of locally advanced ESCC who received two cycles of PD-1 blockade plus chemotherapy, at a median follow-up of 13 months, recurrence still occurred in approximately 25% of patients, indicating a short course of treatment may not be sufficient [16].